Is obesity associated with anemia of chronic disease? A population-based study

Obesity

Volumn 16, Issue 10, 2008, Pages 2356-2361

  Ausk, Karlee J ^a   Ioannou, George N ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FERRITIN; HEMOGLOBIN; IRON; TRANSFERRIN;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD; BODY MASS; CHRONIC DISEASE; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; FEMALE; HEALTH SURVEY; HOSPITALIZATION; HUMAN; INFLAMMATION; MALE; METABOLISM; MIDDLE AGED; NUTRITIONAL STATUS; OBESITY; PATHOPHYSIOLOGY;

ADULT; AGED; ANEMIA; BIOLOGICAL MARKERS; BODY MASS INDEX; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; FERRITINS; HEMOGLOBINS; HUMANS; INFLAMMATION; IRON; MALE; MIDDLE AGED; NUTRITIONAL STATUS; OBESITY; POPULATION SURVEILLANCE; SEVERITY OF ILLNESS INDEX; TRANSFERRIN;

EID: 53849091664     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.353     Document Type: Article

References (27)

1. Day CP. From fat to inflammation. Gastroenterology 2006;130:207-210.
2. Trayhurn P. Endocrine and signalling role of adipose tissue: new perspectives on fat. Acta Physiol Scand 2005;184:285-293.
3. Trayhurn P, Wood IS. Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans 2005;33:1078-1081.
4. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999;282:2131-2135.
5. Weisberg SP, McCann D, Desai M et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112:1796-1808.
6. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999;19:972-978.
7. Mohamed-Ali V, Goodrick S, Rawesh A et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997;82:4196-4200.
8. Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 2004;25:4-7.
9. Alessi MC, Bastelica D, Morange P et al. Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity. Diabetes 2000;49:1374-1380.
10. Lundgren CH, Brown SL, Nordt TK, Sobel BE, Fujii S. Elaboration of type-1 plasminogen activator inhibitor from adipocytes. A potential pathogenetic link between obesity and cardiovascular disease. Circulation 1996;93:106-110.
11. Xu H, Barnes GT, Yang Q et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003;112:1821-1830.
12. Grimble RF. Inflammatory status and insulin resistance. Curr Opin Clin Nutr Metab Care 2002;5:551-559.
13. Means RT Jr. Hepcidin and anaemia. Blood Rev 2004;18:219-225.
14. Nemeth E, Valore EV, Territo M et al. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 2003;101:2461-2463.
15. Fleming RE, Sly WS. Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease. Proc Natl Acad Sci USA 2001;98:8160-8162.
16. Bekri S, Gual P, Anty R et al. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology 2006;131:788-796.
17. National Center for Health Statistics. Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988-1994. U.S. Department of Health and Human Services, Public Health Services, Centers for Disease Control and Prevention, Hyattsville, MD, 1994.
18. Gunter EW, Lewis BG, Koncikowski SM. Laboratory procedures used for the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Environmental Health, Atlanta, GA, and National Center for Health Statistics, Hyattsville, MD 〈http://www.cdc.gov/nchs/data/nhanes/nhanes3/cdrom/nchs/manuals/labman. pdf〉 (1996).
19. Looker AC, Gunter EW, Johnson CL. Methods to assess iron status in various NHANES surveys. Nutr Rev 1995;53:246-254.
20. Looker AC, Dallman PR, Carroll MD, Gunter EW, Johnson CL. Prevalence of iron deficiency in the United States. JAMA 1997;277:973-976.
21. Looker AC, Johnson CL. Prevalence of elevated serum transferrin saturation in adults in the United States. Ann Intern Med 1998;129:940-945.
22. Ioannou GN, Dominitz JA, Weiss NS, Heagerty PJ, Kowdley KV. The effect of alcohol consumption on the prevalence of iron overload, iron deficiency, and iron deficiency anemia. Gastroenterology 2004;126:1293-1301.
23. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002;288:1723-1727.
24. Nordenberg D, Yip R, Binkin NJ. The effect of cigarette smoking on hemoglobin levels and anemia screening. JAMA 1990;264:1556-1559.
25. Weinstein DA, Roy CN, Fleming MD et al. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood 2002;100:3776-3781.
26. Means RT. Hepcidin and cytokines in anaemia. Hematology 2004;9:357-362.
27. Nead KG, Halterman JS, Kaczorowski JM, Auinger P, Weitzman M. Overweight children and adolescents: a risk group for iron deficiency. Pediatrics 2004;114:104-108.